Literature DB >> 22238434

Incidence and virulence determinants of verocytotoxin-producing Escherichia coli infections in the Brussels-Capital Region, Belgium, in 2008-2010.

Glenn Buvens1, Yves De Gheldre, Anne Dediste, Anne-Isabelle de Moreau, Georges Mascart, Anne Simon, Daniël Allemeersch, Flemming Scheutz, Sabine Lauwers, Denis Piérard.   

Abstract

The incidence of verocytotoxin-producing Escherichia coli (VTEC) was investigated by PCR in all human stools from Universitair Ziekenhuis Brussel (UZB) and in selected stools from six other hospital laboratories in the Brussels-Capital Region, Belgium, collected between April 2008 and October 2010. The stools selected to be included in this study were those from patients with hemolytic-uremic syndrome (HUS), patients with a history of bloody diarrhea, patients linked to clusters of diarrhea, children up to the age of 6 years, and stools containing macroscopic blood. Verocytotoxin genes (vtx) were detected significantly more frequently in stools from patients with the selected conditions (2.04%) than in unselected stools from UZB (1.20%) (P = 0.001). VTEC was detected most frequently in patients with HUS (35.3%), a history of bloody diarrhea (5.15%), or stools containing macroscopic blood (1.85%). Stools from patients up to the age of 17 years were significantly more frequently vtx positive than those from adult patients between the ages of 18 and 65 years (P = 0.022). Although stools from patients older than 65 years were also more frequently positive for vtx than those from patients between 18 and 65 years, this trend was not significant. VTEC was isolated from 140 (67.9%) vtx-positive stools. One sample yielded two different serotypes; thus, 141 isolates could be characterized. Sixty different O:H serotypes harboring 85 different virulence profiles were identified. Serotypes O157:H7/H- (n = 34), O26:H11/H- (n = 21), O63:H6 (n = 8), O111:H8/H- (n = 7), and O146:H21/H- (n = 6) accounted for 53.9% of isolates. All O157 isolates carried vtx2, eae, and a complete O island 122 (COI-122); 15 also carried vtx1. Non-O157 isolates (n = 107), however, accounted for the bulk (75.9%) of isolates. Fifty-nine (55.1%) isolates were positive for vtx1, 36 (33.6%) were positive for vtx2, and 12 (11.2%) carried both vtx1 and vtx2. Pulsed-field gel electrophoresis revealed wide genetic diversity; however, small clusters of O157, O26, and O63:H6 VTEC that could have been part of unidentified outbreaks were identified. Antimicrobial resistance was observed in 63 (44.7%) isolates, and 34 (24.1%) showed multidrug resistance. Our data show that VTEC infections were not limited to patients with HUS or bloody diarrhea. Clinical laboratories should, therefore, screen all stools for O157 and non-O157 VTEC using selective media and a method for detecting verocytotoxins or vtx genes.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22238434      PMCID: PMC3318570          DOI: 10.1128/JCM.05317-11

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  56 in total

1.  Bacterial genetic determinants of non-O157 STEC outbreaks and hemolytic-uremic syndrome after infection.

Authors:  Mark E Wickham; Claudia Lupp; Mariola Mascarenhas; Alejandra Vazquez; Brian K Coombes; Nat F Brown; Bryan A Coburn; Wanyin Deng; Jose L Puente; Mohamed A Karmali; B Brett Finlay
Journal:  J Infect Dis       Date:  2006-08-11       Impact factor: 5.226

2.  AB5 subtilase cytotoxin inactivates the endoplasmic reticulum chaperone BiP.

Authors:  Adrienne W Paton; Travis Beddoe; Cheleste M Thorpe; James C Whisstock; Matthew C J Wilce; Jamie Rossjohn; Ursula M Talbot; James C Paton
Journal:  Nature       Date:  2006-10-05       Impact factor: 49.962

3.  Escherichia coli harboring Shiga toxin 2 gene variants: frequency and association with clinical symptoms.

Authors:  Alexander W Friedrich; Martina Bielaszewska; Wen-Lan Zhang; Matthias Pulz; Thorsten Kuczius; Andrea Ammon; Helge Karch
Journal:  J Infect Dis       Date:  2001-12-14       Impact factor: 5.226

4.  Point: Should all stools be screened for Shiga toxin-producing Escherichia coli?

Authors:  Mario J Marcon
Journal:  J Clin Microbiol       Date:  2011-05-04       Impact factor: 5.948

5.  Shiga toxin activatable by intestinal mucus in Escherichia coli isolated from humans: predictor for a severe clinical outcome.

Authors:  Martina Bielaszewska; Alexander W Friedrich; Thomas Aldick; Robin Schürk-Bulgrin; Helge Karch
Journal:  Clin Infect Dis       Date:  2006-10-02       Impact factor: 9.079

6.  Characterization of Saa, a novel autoagglutinating adhesin produced by locus of enterocyte effacement-negative Shiga-toxigenic Escherichia coli strains that are virulent for humans.

Authors:  A W Paton; P Srimanote; M C Woodrow; J C Paton
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

Review 7.  Diarrheagenic Escherichia coli.

Authors:  J P Nataro; J B Kaper
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

8.  The large plasmids of Shiga-toxin-producing Escherichia coli (STEC) are highly variable genetic elements.

Authors:  Werner Brunder; Herbert Schmidt; Matthias Frosch; Helge Karch
Journal:  Microbiology       Date:  1999-05       Impact factor: 2.777

9.  Extended-spectrum beta-lactamase-producing Shiga toxin gene (Stx1)-positive Escherichia coli O26:H11: a new concern.

Authors:  Yoshikazu Ishii; Soichiro Kimura; Jimena Alba; Katsuaki Shiroto; Masanobu Otsuka; Naotaka Hashizume; Kazumichi Tamura; Keizo Yamaguchi
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

10.  Similarity of Shiga toxin-producing Escherichia coli O104:H4 strains from Italy and Germany.

Authors:  Gaia Scavia; Stefano Morabito; Rosangela Tozzoli; Valeria Michelacci; Maria Luisa Marziano; Fabio Minelli; Clarissa Ferreri; Fabio Paglialonga; Alberto Edefonti; Alfredo Caprioli
Journal:  Emerg Infect Dis       Date:  2011-10       Impact factor: 6.883

View more
  21 in total

1.  Assessing the public health risk of Shiga toxin-producing Escherichia coli by use of a rapid diagnostic screening algorithm.

Authors:  Richard F de Boer; Mithila Ferdous; Alewijn Ott; Henk R Scheper; Guido J Wisselink; Max E Heck; John W Rossen; Anna M D Kooistra-Smid
Journal:  J Clin Microbiol       Date:  2015-03-04       Impact factor: 5.948

Review 2.  Global incidence of human Shiga toxin-producing Escherichia coli infections and deaths: a systematic review and knowledge synthesis.

Authors:  Shannon E Majowicz; Elaine Scallan; Andria Jones-Bitton; Jan M Sargeant; Jackie Stapleton; Frederick J Angulo; Derrick H Yeung; Martyn D Kirk
Journal:  Foodborne Pathog Dis       Date:  2014-04-21       Impact factor: 3.171

3.  Enteroaggregative Shiga toxin-producing Escherichia coli of serotype O104:H4 in Belgium and Luxembourg.

Authors:  K De Rauw; S Vincken; L Garabedian; E Levtchenko; I Hubloue; J Verhaegen; J Craeghs; Y Glupczynski; J Mossong; D Piérard
Journal:  New Microbes New Infect       Date:  2014-08-05

4.  Detection of Shiga toxin-producing and other diarrheagenic Escherichia coli by the BioFire FilmArray® Gastrointestinal Panel in human fecal samples.

Authors:  K De Rauw; L Detemmerman; J Breynaert; D Piérard
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-06-03       Impact factor: 3.267

5.  Lessons learned from a textbook outbreak: EHEC-O157:H7 infections associated with the consumption of raw meat products, June 2012, Limburg, Belgium.

Authors:  Toon Braeye; Sarah Denayer; Klara De Rauw; Anmarie Forier; Jurgen Verluyten; Ludo Fourie; Katelijne Dierick; Nadine Botteldoorn; Sophie Quoilin; Pascale Cosse; Jeannine Noyen; Denis Pierard
Journal:  Arch Public Health       Date:  2014-12-15

6.  Molecular characterisation of human Shiga toxin-producing Escherichia coli O26 strains: results of an outbreak investigation, Romania, February to August 2016.

Authors:  Codruţa-Romaniţa Usein; Adriana Simona Ciontea; Cornelia Mãdãlina Militaru; Maria Condei; Sorin Dinu; Mihaela Oprea; Daniela Cristea; Valeria Michelacci; Gaia Scavia; Lavinia Cipriana Zota; Alina Zaharia; Stefano Morabito
Journal:  Euro Surveill       Date:  2017-11

7.  Enterohemorrhagic Escherichia coli as causes of hemolytic uremic syndrome in the Czech Republic.

Authors:  Monika Marejková; Květa Bláhová; Jan Janda; Angelika Fruth; Petr Petráš
Journal:  PLoS One       Date:  2013-09-06       Impact factor: 3.240

8.  Shiga toxin-producing escherichia coli infections in Norway, 1992-2012: characterization of isolates and identification of risk factors for haemolytic uremic syndrome.

Authors:  Lin T Brandal; Astrid L Wester; Heidi Lange; Inger Løbersli; Bjørn-Arne Lindstedt; Line Vold; Georg Kapperud
Journal:  BMC Infect Dis       Date:  2015-08-11       Impact factor: 3.090

9.  Evolution of enterohemorrhagic escherichia coli O26 based on single-nucleotide polymorphisms.

Authors:  Stefan Bletz; Martina Bielaszewska; Shana R Leopold; Robin Köck; Anika Witten; Jörg Schuldes; Wenlan Zhang; Helge Karch; Alexander Mellmann
Journal:  Genome Biol Evol       Date:  2013       Impact factor: 3.416

10.  Shiga toxin-producing Escherichia coli O157 is more likely to lead to hospitalization and death than non-O157 serogroups--except O104.

Authors:  Karina Preußel; Michael Höhle; Klaus Stark; Dirk Werber
Journal:  PLoS One       Date:  2013-11-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.